Kasanuki, Hiroshi <br/><br/>
Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE).  [electronic resource] 

 -  European heart journal  May 2009 
 - 1203-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-9645 
<br/><br/><label>Standard No.: </label>10.1093/eurheartj/ehp101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angina Pectoris--epidemiology<br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Benzimidazoles--therapeutic use<br/>Biphenyl Compounds<br/>Blood Pressure--drug effects<br/>Coronary Artery Disease--drug therapy<br/>Death, Sudden, Cardiac--epidemiology<br/>Diabetes Mellitus--epidemiology<br/>Female<br/>Heart Failure--epidemiology<br/>Humans<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--epidemiology<br/>Statistics as Topic<br/>Stroke--epidemiology<br/>Tetrazoles--therapeutic use<br/>Young Adult